Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Relevant Outcomes Improvement Program in High Risk HR-positive Breast Cancer

NCT07531693 is registered in ClinicalTrials.gov with Institut fuer Frauengesundheit as lead sponsor.

NCT NCT07531693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07531693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Relevant Outcomes Improvement Program in High Risk HR-positive Breast Cancer
Lead sponsor
Institut fuer Frauengesundheit
Phase
Observational
Overall status
Recruiting
Start date
February 19, 2026
Completion date
March 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hr+/her2- early breast cancer